EP0785992A4 - Conditional transformation of genetically engineered cells - Google Patents
Conditional transformation of genetically engineered cellsInfo
- Publication number
- EP0785992A4 EP0785992A4 EP95937629A EP95937629A EP0785992A4 EP 0785992 A4 EP0785992 A4 EP 0785992A4 EP 95937629 A EP95937629 A EP 95937629A EP 95937629 A EP95937629 A EP 95937629A EP 0785992 A4 EP0785992 A4 EP 0785992A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- genetically engineered
- engineered cells
- conditional transformation
- conditional
- transformation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
- C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/72—Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32893194A | 1994-10-25 | 1994-10-25 | |
US328931 | 1994-10-25 | ||
PCT/US1995/013776 WO1996012796A1 (en) | 1994-10-25 | 1995-10-25 | Conditional transformation of genetically engineered cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0785992A1 EP0785992A1 (en) | 1997-07-30 |
EP0785992A4 true EP0785992A4 (en) | 1999-12-22 |
Family
ID=23283095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95937629A Withdrawn EP0785992A4 (en) | 1994-10-25 | 1995-10-25 | Conditional transformation of genetically engineered cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0785992A4 (en) |
JP (1) | JPH11511643A (en) |
AU (1) | AU3968595A (en) |
WO (1) | WO1996012796A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE388724T1 (en) * | 1998-01-08 | 2008-03-15 | Univ Washington | METHODS FOR CONTROLLING CELL DIFFERENTIATION AND GROWTH BY USING A FUSION PROTEIN AND AN ACTIVE SUBSTANCE |
EP1079859B1 (en) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US6887842B1 (en) | 1999-11-19 | 2005-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
AU2044001A (en) | 1999-11-19 | 2001-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Targeted bifunctional molecules and therapies based thereon |
US7220552B1 (en) | 1999-11-19 | 2007-05-22 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and their use in the disruption of protein-protein interactions |
AU2002317841A1 (en) | 2001-06-22 | 2003-01-08 | Roche Diagnostics Gmbh | Use of fkbp chaperones as expression tool |
EP1641927B1 (en) | 2003-02-18 | 2015-07-08 | Baylor College of Medicine | Induced activation in dendritic cells |
WO2008049113A2 (en) | 2006-10-19 | 2008-04-24 | Baylor College Of Medicine | Generating an immune response by inducing cd40 and pattern recognition receptors |
AU2009292996B2 (en) | 2008-09-22 | 2015-04-23 | Baylor College Of Medicine | Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters |
US9089520B2 (en) | 2010-05-21 | 2015-07-28 | Baylor College Of Medicine | Methods for inducing selective apoptosis |
US10634668B2 (en) | 2012-09-13 | 2020-04-28 | Takara Bio Usa, Inc. | Modifiable chemical inducers of proximity and methods of using the same |
US9434935B2 (en) | 2013-03-10 | 2016-09-06 | Bellicum Pharmaceuticals, Inc. | Modified caspase polypeptides and uses thereof |
WO2014151960A2 (en) | 2013-03-14 | 2014-09-25 | Bellicum Pharmaceuticals, Inc. | Methods for controlling t cell proliferation |
AU2014274916B2 (en) | 2013-06-05 | 2019-10-31 | Bellicum Pharmaceuticals, Inc. | Methods for inducing partial apoptosis using caspase polypeptides |
CA2905229C (en) | 2013-06-11 | 2023-10-10 | Clontech Laboratories, Inc. | Protein enriched microvesicles and methods of making and using the same |
CN111849912B (en) | 2014-02-14 | 2024-03-15 | 贝里坤制药股份有限公司 | Method for activating T cells using inducible chimeric polypeptides |
JP6868554B2 (en) | 2014-09-02 | 2021-05-12 | ベリカム ファーマシューティカルズ, インコーポレイテッド | Co-stimulation of chimeric antigen receptor with MyD88 and CD40 polypeptides |
EP3215522B1 (en) | 2014-11-03 | 2021-12-01 | Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum | T cell receptors directed against bob1 and uses thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023550A2 (en) * | 1992-05-18 | 1993-11-25 | Genentech, Inc. | Activation of oligomerizing receptors by using fused receptor ligands |
WO1994018317A1 (en) * | 1993-02-12 | 1994-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated transcription of targeted genes and other biological events |
WO1995002684A1 (en) * | 1993-07-16 | 1995-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated apoptosis |
WO1996006111A1 (en) * | 1994-08-18 | 1996-02-29 | Ariad Gene Therapeutics, Inc. | Regulatable elimination of gene expression, gene product function and engineered host cells |
-
1995
- 1995-10-25 JP JP8514133A patent/JPH11511643A/en active Granted
- 1995-10-25 EP EP95937629A patent/EP0785992A4/en not_active Withdrawn
- 1995-10-25 AU AU39685/95A patent/AU3968595A/en not_active Abandoned
- 1995-10-25 WO PCT/US1995/013776 patent/WO1996012796A1/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023550A2 (en) * | 1992-05-18 | 1993-11-25 | Genentech, Inc. | Activation of oligomerizing receptors by using fused receptor ligands |
WO1994018317A1 (en) * | 1993-02-12 | 1994-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated transcription of targeted genes and other biological events |
WO1995002684A1 (en) * | 1993-07-16 | 1995-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated apoptosis |
WO1996006111A1 (en) * | 1994-08-18 | 1996-02-29 | Ariad Gene Therapeutics, Inc. | Regulatable elimination of gene expression, gene product function and engineered host cells |
Non-Patent Citations (6)
Title |
---|
ARONHEIM A ET AL: "Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the ras signaling pathway", CELL, vol. 78, 23 September 1994 (1994-09-23), NA US, pages 949 - 961, XP002117493 * |
HOLSINGER L J ET AL: "Signal transduction in T lymphocytes using a conditional allele of Sos.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1995 OCT 10) 92 (21) 9810-4., XP002117491 * |
KOLANUS, WALDEMAR ET AL: "T cell activation by clustered tyrosine kinases", CELL (CAMBRIDGE, MASS.) ( 1993 ), 74(1), 171-83, XP002117494 * |
PRUSCHY M N ET AL: "Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012.", CHEMISTRY AND BIOLOGY, (1994 NOV) 1 (3) 163-72., XP002117492 * |
See also references of WO9612796A1 * |
SPENCER D M ET AL: "A general strategy for producing conditional alleles of Src-like tyrosine kinases.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1995 OCT 10) 92 (21) 9805-9., XP002117490 * |
Also Published As
Publication number | Publication date |
---|---|
JPH11511643A (en) | 1999-10-12 |
EP0785992A1 (en) | 1997-07-30 |
WO1996012796A1 (en) | 1996-05-02 |
AU3968595A (en) | 1996-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0785992A4 (en) | Conditional transformation of genetically engineered cells | |
HU9500264D0 (en) | An improved method of agrobactenium-mediated transformation of cultvred soyhean cells | |
GB9310545D0 (en) | Power coupling | |
EP0797454A4 (en) | Improved adenoviral vectors and producer cells | |
PL340677A1 (en) | Wind-propelled power plant | |
GB9204583D0 (en) | Recombinant plant enzyme | |
EP1034288A4 (en) | Methods of isolating and using cd7+cd34-lin-hematopoietic cells | |
AU3491195A (en) | Genetically engineered cells that produce dopamine | |
HUP0002903A3 (en) | Plant transformation methods | |
AU3243595A (en) | Genetically engineered swine cells | |
GB9605334D0 (en) | Biodecontamination reactor | |
GB9809178D0 (en) | Nuclear reprogramming of somatic cells | |
AU2682895A (en) | EG Cells of Ungulates | |
GB2317168B (en) | Sequential batch reactor | |
IL113438A0 (en) | Compositions and methods for cell transformation | |
PL357156A1 (en) | Defoliation and minimization of plant regrowth following defoliation | |
IL114688A0 (en) | Vectors and transformed host cells | |
GB9614202D0 (en) | Reactor | |
GB2309986B (en) | Structure of interlocking members | |
GB9619633D0 (en) | Recombinant plant cells | |
ZA975120B (en) | Floating power plant | |
GB9413028D0 (en) | Culturing of cells | |
TW306310U (en) | Improved structure of car-assembly type robot | |
GB9207276D0 (en) | Modified cells | |
AU7464494A (en) | Xenogeneic scid model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970523 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19991105 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 20010104 |